President Trump's new prescription portal, TrumpRx.gov, highlights steep discounts for GLP‑1 weight‑loss drugs but currently lists fewer than 45 medicines, with more than 30 coming from Pfizer. Only five manufacturers had posted drugs despite reported deals with 16 companies. Experts say most insured patients will still be better off using their health plans, though selected groups — such as fertility-drug users or those who pay out of pocket for GLP‑1s — may benefit.
TrumpRx.gov Promises Big GLP‑1 Cuts but Offers Limited Savings for Most Patients
U.S. President Donald Trump speaks during an event unveiling the TrumpRx drug discount site, in the South Court Auditorium on the White House campus, in Washington, D.C., U.S., February 5, 2026. REUTERS/Al Drago
President Donald Trump's new prescription-drug portal, TrumpRx.gov, launched this week but currently delivers limited savings for most Americans beyond discounted GLP‑1 weight‑loss medications, experts say. The site lists discounts for under 45 medicines — more than 30 of them from Pfizer — and only five manufacturers had posted drugs as of Friday despite reported agreements with 16 companies.
What the Site Does — And Doesn't
TrumpRx does not sell drugs directly. Instead, the portal provides manufacturer coupons or directs users to company-run purchase pages, offering discounts off list prices that range roughly from 33% to more than 90%. Even after those reductions, some medicines remain expensive: Pfizer's rheumatoid arthritis drug Xeljanz appears at about one-third off its list price but still costs more than $1,500 for a monthly supply.
GLP‑1 Price Reductions
The administration negotiated steep cuts for GLP‑1 weight‑loss drugs, reporting prices as low as $149 a month and averaging around $350 a month — down from more than $1,000 a month previously. Those reductions are aimed mainly at people who buy these drugs outside of insurance coverage.
Other Notable Listings
Fertility drug Gonal‑F (Merck KGaA unit EMD Serono) is listed at $168, an 83% reduction from the list price. However, many of the medicines on the site already face low-cost generic competition on the market, which limits the portal's potential savings for insured patients.
Expert Reaction
"A small proportion of people may be able to find a better deal on their medicines," said Stacie Dusetzina, Professor of Health Policy at Vanderbilt University School of Medicine. "For most people in the US, they are likely to be better off paying for their medicines with their health insurance and not using TrumpRx, assuming the drug they need is covered by their plan."
Juliette Cubanski, deputy director for Medicare policy at the Kaiser Family Foundation, noted that discounts could help patients who need fertility drugs or other treatments often poorly covered by insurance, but cautioned that even reduced prices — for example, roughly $200 a month for some GLP‑1s — may remain unaffordable for many.
Looking Ahead
The White House says it will add more medicines from other manufacturers in the coming months. For now, the portal appears to deliver headline-grabbing price cuts for a subset of drugs while offering limited, immediate benefit for the majority of insured patients who obtain medicines through their plans.
Reporting by Michael Erman in New York; additional reporting by Puyaan Singh and Padmanabhan Ananthan in Bengaluru; edited by Matthew Lewis.
Help us improve.
